Carrol Gamble

@prw_paula @OBrienK57 @LivUniHDS @livuninews @LivUniIPH @livuni_LCTC @Bally_Tracy @KevinJMunro @UKCTUNetwork

After 18 years from first discussion to publication nejm.org/doi/full/10.10… it’s time to celebrate the TOPs trial at the top. Thanks to everyone who helped along the way

It doesn’t matter how innovative or efficient your trial design is, unless your trial is managed well, it will likely not succeed as planned. Having high quality #TrialManagement is a fundamental requirement 1/8 #MethodologyMonday

Tune into @thismorning today, where I will answer your questions on the #perimenopause and #menopause. Explore our resources on the free @balanceMeno website and app #thismorning

Fantastic to get the opportunity to share the @CopeTrial embedded study findings at #ICTMC2022 Go @kerry_woolfall 👏 Thank you to our amazing #NHS & the women involved for your work helping to answer such important questions 🤰 @BethDeja @adweeks @livuni_LCTC @ResearchSanyu

Fantastic team night out @livuni_LCTC #ICTMC2022

Fascinating keynote from @IsabelleBoutron at #ICTMC2022 , ending with the message that we can always do more to ensure better trials

Trial funders take note! Be more like ⁦@hrbtmrn⁩ and ask applicants whether they have searched the COMET database to check whether a COS exits #ICTMC2022

📸 And then there was.... many!! @ictmc2022 Proud of how much our network has grown, & eager to work with our colleagues & friends across @hrbireland infrastructures on #trialsmethodology (we also have a bit of fun along the way!)

Great to hear from @TimoTolppa about the important work on the applicability of PRECIS-2 in LMICs. Sounds like an exciting programme of research ahead. #ICTMC22

We had a great time at the #UKTMN networking event at #ICTMC2022 yesterday! Finally some face-face discussion with our lovely members! Really helpful to discuss our #professionaldevelopment work and get feedback directly from TMs! #UKTMN2022

Good turnout at #ictmc2022 for Jess Griffiths’ talk about estimating the carbon footprint of a clinical trial ⁦@MRCNIHRTMRP⁩ ⁦@mattsydes⁩ ⁦@kerryhood⁩ @carrol_gamble ⁦@livuni_LCTC⁩ ⁦@GilliesKatie⁩

The next TMRP webinar hosted by @UKTMN: GCP but not as you know it… Development of Good Statistical Practice Training Wednesday 9 June 2021 – 1-2pm Presented by Prof Deb Stocken (University of Leeds) For more info and registration: eventbrite.co.uk/e/tmrp-webinar…

@kerryhood @GilliesKatie @hsru_aberdeen @aberdeenuni Now that sounds like a plan!!

Found out this week I am being promoted to Reader @hsru_aberdeen @aberdeenuni. Huge thanks to everyone locally, nationally & internationally who has contributed to & supported my research. This represents all of that energy and enthusiasm. But sorry, I ain't sharing the Bolli!

@GilliesKatie @kerryhood @hsru_aberdeen @aberdeenuni Excellent news! Are you sure you can’t be persuaded about the Bolli?

@kerryhood @hsru_aberdeen @aberdeenuni Thanks Kerry. Great collaborators maketh the woman!

Calling all #Funders - Do you fund #ClinicalTrials that include collection of #QualitiativeData? @QUESTScentre would welcome your views sharing this type of data. Please contact megan.mccarthy@nuigalway.ie to take part & share your views. #TrialsMethodology

And more from our amazing network. Levetiracetam not clinically or cost effective first line in generalised epilepsy. @sanad2trial @ILAEBRITISH @theABN_Info @BPNA_org @epilepsyaction @epilepsy_liv @livuni_LCTC @CHEMEBangor authors.elsevier.com/sd/article/S01…

Fantastic achievement from our UK network. Lamotrigine clinically & cost effective first line in focal epilepsy, levetiracetam and zonisamide are not. @sanad2trial @ILAEBRITISH @theABN_Info @BPNA_org @epilepsyaction @epilepsy_liv @livuni_LCTC @CHEMEBangor authors.elsevier.com/sd/article/S01…

We have now received all the regulatory approvals we need for @HEAL_COVID & will be sending out document packs to the >60 hospitals who have so far expressed an interest in joining our study in the next 48h. Don’t miss out, get in touch (info in bio) & join us! #AvoidFOMO